Josée Laganière

3.0k citations

23 papers · 2.2k indexed · 1 hit paper · h-index 15

Molecular Biology top 5%
Genetics top 5%
Cellular and Molecular Neuroscience top 5%
Physiology top 10%
Oncology

Co-authors: Vincent Giguère Geneviève Deblois Alain R. Bataille François Robert Céline Lefèbvre Philip D. Gregory Fyodor D. Urnov Lauren Fong
Topics: Estrogen and related hormone effects (6 papers)CRISPR and Genetic Engineering (5 papers)Genomics and Chromatin Dynamics (4 papers)
Cited by: Aging Molecular Biology Genetics
Journals: Cell Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: Canada United States Japan

In The Last Decade

Josée Laganière

21 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations

2011 555 citations Frank Soldner, Josée Laganière et al. Cell profile →

Peers

Countries citing papers authored by Josée Laganière

Since Specialization

Citations

This map shows the geographic impact of Josée Laganière's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josée Laganière with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josée Laganière more than expected).

Fields of papers citing papers by Josée Laganière

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josée Laganière. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josée Laganière. The network helps show where Josée Laganière may publish in the future.

Co-authorship network of co-authors of Josée Laganière

This figure shows the co-authorship network connecting the top 25 collaborators of Josée Laganière. A scholar is included among the top collaborators of Josée Laganière based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josée Laganière. Josée Laganière is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CRISPR-Cas9-driven antigen conversion of clinically relevant blood group systems 2025 ·Human Molecular Genetics ·(unknown),(unknown),Yannick Doyon,Josée Laganière	0
2	AA2P-mediated DNA demethylation synergizes with stem cell agonists to promote expansion of hematopoietic stem cells 2023 ·Cell Reports Methods ·(unknown),Harinad B. Maganti,(unknown),(unknown),Tanvir Hasan,(unknown),(unknown),(unknown),Josée Laganière,Julie Audet,Nicolas Pineault	1
3	Prevalence of weak D phenotypes in the general population of Québec, Canada: A focus on weak D type 42 2023 ·Vox Sanguinis ·Mathieu Drouin,(unknown),Maryse St‐Louis,Antoine Lewin,Josée Laganière	0
4	Accessory-cell-free differentiation of hematopoietic stem and progenitor cells into mature red blood cells 2023 ·Cytotherapy ·(unknown),(unknown),Yannick Doyon,Josée Laganière	2
5	High prevalence of weakDtype 42 in a large‐scaleRHDgenotyping program in the province ofQuebec (Canada) 2021 ·Transfusion ·(unknown),(unknown),(unknown),Antoine Lewin,Josée N. Lavoie,Josée Laganière,(unknown),(unknown),Nancy Robitaille	7
6	Marker-free coselection for CRISPR-driven genome editing in human cells 2017 ·Nature Methods ·Daniel Agudelo,(unknown),Lusiné Bozoyan,Caroline Huard,Sophie Carter,Jérémy Loehr,(unknown),Mathieu Drouin,Jayme Salsman,Graham Dellaire,Josée Laganière,Yannick Doyon	110
7	LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: Reversal by gene correction 2013 ·Neurobiology of Disease ·Laurie H. Sanders,Josée Laganière,Oliver Cooper,Sally K. Mak,(unknown),Ying Huang,David E. Paschon,(unknown),Ramya Sundararajan,Fyodor D. Urnov,J. William Langston,Philip D. Gregory,H. Steve Zhang,J. Timothy Greenamyre,Ole Isacson,Birgitt Schüle	216
8	Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutationsbreakdown → 2011 ·Cell ·Frank Soldner,Josée Laganière,Albert Cheng,Dirk Hockemeyer,Qing Gao,R. Alagappan,Vikram Khurana,Lawrence I. Golbe,Richard H. Myers,Susan Lindquist,Lei Zhang,Dmitry Guschin,Lauren Fong,(unknown),Xiangdong Meng,Fyodor D. Urnov,Edward J. Rebar,Philip D. Gregory,(unknown),Rudolf Jaenisch	555
9	Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations 2011 ·Cell ·F. Söldner,Josée Laganière,Albert Cheng,Dirk Hockemeyer,Qing Gao,R. Alagappan,Vikram Khurana,Lawrence I. Golbe,Richard H. Myers,Susan Lindquist,Lei Zhang,Dmitry Guschin,Lauren Fong,(unknown),(unknown),Fyodor D. Urnov,Edward J. Rebar,Philip D. Gregory,(unknown),Rudolf Jaenisch	21
10	An Engineered Zinc Finger Protein Activator of the Endogenous Glial Cell Line-Derived Neurotrophic Factor Gene Provides Functional Neuroprotection in a Rat Model of Parkinson's Disease 2010 ·Journal of Neuroscience ·Josée Laganière,Adrian P. Kells,(unknown),Dmitry Guschin,David E. Paschon,Xiangdong Meng,Lauren Fong,(unknown),Edward J. Rebar,Philip D. Gregory,Krystof S. Bankiewicz,John Forsayeth,(unknown)	56
11	Genome-Wide Identification of Direct Target Genes Implicates Estrogen-Related Receptor α as a Determinant of Breast Cancer Heterogeneity 2009 ·Cancer Research ·Geneviève Deblois,Jacqueline A. Hall,(unknown),Josée Laganière,Majid Ghahremani,Morag Park,Michael Hallett,Vincent Giguère	143
12	Nuclear receptor ERRα and coactivator PGC-1β are effectors of IFN-γ-induced host defense 2007 ·Genes & Development ·Junichiro Sonoda,Josée Laganière,(unknown),Grant D. Barish,Ling-Wa Chong,Xiangli Li,Immo E. Scheffler,Dennis Mock,Alain R. Bataille,(unknown),Chih‐Hao Lee,Vincent Giguère,Ronald M. Evans	180
13	Genome-wide computational prediction of transcriptional regulatory modules reveals new insights into human gene expression 2006 ·Genome Research ·Mathieu Blanchette,Alain R. Bataille,Xiaoyu Chen,Christian Poitras,Josée Laganière,Céline Lefèbvre,Geneviève Deblois,Vincent Giguère,Vincent Ferretti,Dominique Bergeron,Benoit Coulombe,François Robert	205
14	Transcriptional Regulation of Dehydroepiandrosterone Sulfotransferase (SULT2A1) by Estrogen-Related Receptor α 2005 ·Endocrinology ·(unknown),(unknown),Takashi Suzuki,Bobbie Mayhew,Hironobu Sasano,Vincent Giguère,Josée Laganière,Bruce R. Carr,William E. Rainey	43
15	A Single Nucleotide in an Estrogen-Related Receptor α Site Can Dictate Mode of Binding and Peroxisome Proliferator-Activated Receptor γ Coactivator 1α Activation of Target Promoters 2005 ·Molecular Endocrinology ·(unknown),Josée Laganière,Vincent Giguère	45
16	Location analysis of estrogen receptor α target promoters reveals that FOXA1 defines a domain of the estrogen response 2005 ·Proceedings of the National Academy of Sciences ·Josée Laganière,Geneviève Deblois,Céline Lefèbvre,Alain R. Bataille,François Robert,Vincent Giguère	298
17	A Polymorphic Autoregulatory Hormone Response Element in the Human Estrogen-related Receptor α (ERRα) Promoter Dictates Peroxisome Proliferator-activated Receptor γ Coactivator-1α Control of ERRα Expression 2004 ·Journal of Biological Chemistry ·Josée Laganière,Gilles B. Tremblay,Catherine R. Dufour,Sylvie Giroux,François Rousseau,Vincent Giguère	149
18	Endothelium properties of a tissue-engineered blood vessel for small-diameter vascular reconstruction 2004 ·Journal of Vascular Surgery ·Murielle Rémy-Zolghadri,Josée Laganière,(unknown),Lucie Germain,François A. Auger	27
19	Nuclear Receptor Target Gene Discovery Using High-Throughput Chromatin Immunoprecipitation 2003 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Josée Laganière,Geneviève Deblois,Vincent Giguère	11
20	A Home‐based Description of Attachment in Physically Disabled Infants 2002 ·Social Development ·Réjean Tessier,George M. Tarabulsy,(unknown),Josée Laganière,Marthe Monique Gagnon,(unknown)	7

About Josée Laganière

Josée Laganière is a scholar working on Hematology, Genetics and Cellular and Molecular Neuroscience, having authored 23 papers that have together received 2.2k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (6 papers), CRISPR and Genetic Engineering (5 papers) and Genomics and Chromatin Dynamics (4 papers). The work is most often cited by research in Aging (57 citations), Molecular Biology (1.7k citations) and Genetics (631 citations). Josée Laganière has collaborated with scholars based in Canada, United States and Japan. Frequent co-authors include Vincent Giguère, Geneviève Deblois, Alain R. Bataille, François Robert, Céline Lefèbvre, Philip D. Gregory, Fyodor D. Urnov, Lauren Fong, Edward J. Rebar and Dmitry Guschin. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact